Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | CFH |
| Upstream (Parents) |
|---|
| (<<) CFHR1///CFH → CFH |
| (<<) HSD11B1 → CFH |
| (<<) SERPING1 → CFH |
| Downstream (Children) |
|---|
| CFH → METTL7A (>>) |
| CFH → COL18A1 (>>) |
| CFH → PLA1A (>>) |
| CFH → TFPI (>>) |
| CFH → MPPED1 (>>) |
| CFH → ACSS3 (>>) |
| CFH → PPP1R3C (>>) |
| CFH → PLSCR4 (>>) |
| CFH → GHR (>>) |
| CFH → ABCA6 (>>) |
| CFH → MAOB (>>) |
| CFH → CFHR1///CFH (>>) |
| CFH → C7 (>>) |
| CFH → MPDZ (>>) |
| CFH → ENPEP (>>) |
| CFH → ASPA (>>) |
| CFH → FBXO17 (>>) |
| CFH → CD1D (>>) |
| CFH → FNDC4 (>>) |
| CFH → SERPING1 (>>) |
| CFH → C1RL (>>) |
| CFH → CD302 (>>) |
| CFH → FOLH1 (>>) |
| CFH → C5orf4 (>>) |
